These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 17057810)
1. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Tse DT Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810 [TBL] [Abstract][Full Text] [Related]
2. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976 [TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Tse DT; Benedetto P; Dubovy S; Schiffman JC; Feuer WJ Am J Ophthalmol; 2006 Jan; 141(1):44-53. PubMed ID: 16386975 [TBL] [Abstract][Full Text] [Related]
11. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma. Yang J; Zhou C; Wang Y; Fan X; Jia R BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360 [TBL] [Abstract][Full Text] [Related]
12. American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma. Ahmad SM; Esmaeli B; Williams M; Nguyen J; Fay A; Woog J; Selvadurai D; Rootman J; Weis E; Selva D; McNab A; DeAngelis D; Calle A; Lopez A Ophthalmology; 2009 Jun; 116(6):1210-5. PubMed ID: 19395039 [TBL] [Abstract][Full Text] [Related]
13. [Imaging feature and clinical histological analysis of 12 adenoid cystic carcinoma of the lacrimal gland]. Wang F; Sun FY; Guo XX; Xia S; Tang DR Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):47-51. PubMed ID: 23601466 [TBL] [Abstract][Full Text] [Related]
14. Intra-arterial Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma. Zhang M; Fathy C; Breazzano MP; Hollar M; Barahimi B Int Ophthalmol Clin; 2017; 57(1):143-152. PubMed ID: 27898620 [No Abstract] [Full Text] [Related]
15. Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland. Hung JY; Wei YH; Huang CH; Chen LW; Fuh CS; Liao SL Jpn J Ophthalmol; 2019 Jul; 63(4):344-351. PubMed ID: 31134459 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma. Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839 [TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Esmaeli B; Ahmadi MA; Youssef A; Diba R; Amato M; Myers JN; Kies M; El-Naggar A Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):22-6. PubMed ID: 14752305 [TBL] [Abstract][Full Text] [Related]
18. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland. Le Tourneau C; Razak AR; Levy C; Calugaru V; Galatoire O; Dendale R; Desjardins L; Gan HK Br J Ophthalmol; 2011 Nov; 95(11):1483-9. PubMed ID: 21183517 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland. Han J; Kim YD; Woo KI; Sobti D Ophthalmic Plast Reconstr Surg; 2018; 34(1):74-78. PubMed ID: 28221296 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome. Anjum S; Sen S; Chosdol K; Bakhshi S; Kashyap S; Pushker N; Bajaj MS; Meel R; Sharma MC Ann Diagn Pathol; 2022 Feb; 56():151846. PubMed ID: 34749048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]